Literature DB >> 2237762

High or low hepaticojejunostomy for bile duct strictures?

J Terblanche1, C S Worthley, R A Spence, J E Krige.   

Abstract

The 19 patients who underwent 22 postoperative repairs of bile duct stricture in our institution between 1973 and 1984 were evaluated to assess whether the recognition of the tenuous blood supply of the supraduodenal bile duct in 1979 had improved the results thereafter. Thirteen of these 22 operations followed a previous biliary tract repair; in 10 of the operations a low anastomosis had been performed without taking blood supply into account. Follow-up was complete and ranged from 5 to 15 years. There were no operative deaths and minimal morbidity. There were three deaths at a later time. Five of the 11 patients treated by surgery to 1979 had a clinically unsatisfactory result: recurrent strictures developed in all five patients. All but one of the eight patients receiving a high hepaticojejunostomy from 1980 had a clinically satisfactory result with no recurrent strictures. The one exception was the patient who had a second repair with separate high right and left hepatic duct anastomoses and who has ongoing symptoms from preexisting secondary sclerosing cholangitis. The results in the five high repairs performed for low strictures were particularly striking: All five were asymptomatic. This study lends support to the hypothesis of an ischemic basis for biliary strictures and to the recommendation that strictures be repaired with a high hepaticojejunostomy.

Entities:  

Mesh:

Year:  1990        PMID: 2237762

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  29 in total

1.  Choledochal Cystic Diseases.

Authors:  Stephen D. Bruns; Thomas A. Broughan
Journal:  Curr Treat Options Gastroenterol       Date:  2001-04

2.  Timing and risk factors of hepatectomy in the management of complications following laparoscopic cholecystectomy.

Authors:  J Li; A Frilling; S Nadalin; C E Broelsch; M Malago
Journal:  J Gastrointest Surg       Date:  2011-11-09       Impact factor: 3.452

3.  [Surgical treatment of benign lesions and strictures of the bile ducts].

Authors:  J Y Tracey; A R Moossa
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

4.  Hepaticojejunostomy vs. end-to-end biliary reconstructions in the treatment of iatrogenic bile duct injuries.

Authors:  Beata Jabłońska; Paweł Lampe; Marek Olakowski; Zygmunt Górka; Andrzej Lekstan; Tomasz Gruszka
Journal:  J Gastrointest Surg       Date:  2009-03-06       Impact factor: 3.452

Review 5.  Iatrogenic bile duct injuries: etiology, diagnosis and management.

Authors:  Beata Jabłońska; Paweł Lampe
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

Review 6.  The current diagnosis and treatment of benign biliary stricture.

Authors:  Hiroshi Shimada; Itaru Endo; Kazuhiro Shimada; Ryusei Matsuyama; Noritoshi Kobayashi; Kensuke Kubota
Journal:  Surg Today       Date:  2012-09-22       Impact factor: 2.549

7.  [Leakage after biliary and pancreatic surgery].

Authors:  U T Hopt; F Makowiec; U Adam
Journal:  Chirurg       Date:  2004-11       Impact factor: 0.955

8.  Surgical management in biliary restricture after Roux-en-Y hepaticojejunostomy for bile duct injury.

Authors:  Ji-Qi Yan; Cheng-Hong Peng; Jia-Zeng Ding; Wei-Ping Yang; Guang-Wen Zhou; Yong-Jun Chen; Zong-Yuan Tao; Hong-Wei Li
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

9.  Factors Affecting Short-Term and Long-Term Outcomes After Bilioenteric Reconstruction for Post-cholecystectomy Bile Duct Injury: Experience at a Tertiary Care Centre.

Authors:  Virinder K Bansal; Asuri Krishna; Mahesh C Misra; Prem Prakash; Subodh Kumar; Karthik Rajan; Divya Babu; Pramod Garg; Atin Kumar; Rajeshwari S
Journal:  Indian J Surg       Date:  2013-02-13       Impact factor: 0.656

10.  Management of major bile duct injuries after laparoscopic cholecystectomy.

Authors:  L Kaman; A Behera; R Singh; R N Katariya
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.